Professor, Group Leader
Medical Center University Freiburg, Head Research and Clinical Research Coordination, Comprehensive Cancer Center Freiburg
Freiburg, Germany
Prof. Dr. rer. nat. Tanja Nicole Hartmann is professor at the Medical Faculty of the University of Freiburg, Germany. She leads a research group in the Department of Medicine I at the University Medical Center Freiburg and serves as Scientific Lead for Research and Clinical Trials, Coordination at the Comprehensive Cancer Center Freiburg (CCCF), where she is also engaged in patient empowerment and outreach activities.
Prof. Hartmann’s group investigates the cellular and molecular mechanisms by which the CLL microenvironment promotes tumor survival, therapy resistance, and disease progression, with a particular emphasis on integrin biology and cell adhesion processes. Her laboratory works at the interface of immunology, cell biology, and translational oncology, applying advanced microscopy (confocal, super-resolution, shear flow, time-lapse), machine learning–based analysis, spectral flow cytometry, and in vivo models to dissect adhesion-driven signaling in hematologic malignancies.
She studied Biology at the University of Freiburg, where she received her PhD in 2002. After postdoctoral research in Freiburg and as a Minerva Fellow at the Weizmann Institute of Science in Israel, she established her independent group in 2008 at the Salzburg Cancer Research Institute, where she later became Associate Professor of Tumor Biology at the Paracelsus Medical University. She holds habilitations in Tumor Biology (PMU Salzburg, 2013), Molecular Biology (University of Salzburg, 2015), and Experimental Medicine (University of Freiburg, 2021).
Beyond Adhesion: Integrin Crosstalk With the BCR in CLL
Saturday, September 13, 2025
13:55 - 14:15 CEST
